Fagofarma

16/12/2025

🎉 VoM2026 registration is OPEN! 🎉

Yes, it’s true — before Christmas 🎄😉
Viruses of Microbes 2026 is coming to , and we couldn’t be more excited!
At FAGOFARMA, bacteriophages are our daily business 🦠💙, so bringing together the global phage and microbial virus community feels close to our hearts.
Expect great science, inspiring talks, new collaborations — and a fantastic atmosphere in one of Europe’s most beautiful cities 🇨🇿✨
🎁 Give yourself a scientific gift and register early!
👉 More info via the official VoM2026 channels.

Still looking for the perfect Christmas gift? We have good news, the registration is ON. Check https://www.vom2026.org/registration

09/12/2025

✨ Hledáme nového kolegu do týmu FAGOFARMA! ✨

Chcete pracovat na vývoji inovativních biologických přípravků a posouvat hranice analytických metod?
Do našeho týmu hledáme Specialistu vývoje a aplikace analytických metod.

Pokud máte zkušenosti s LC-MS a HPLC, baví vás věda, vývoj a práce v menším přátelském kolektivu, nenechte si ujít tuto příležitost.

👉 Co nabízíme? Stabilní zázemí, odborný růst, podporu zkušených kolegů a odpovídající ohodnocení.
👉 Koho hledáme? Absolventa s minimálně 3letou zkušeností v oboru, který se nebojí samostatné práce a je komunikativní v AJ i ČJ.

Zaujala vás tato pozice?
📩 Pošlete svůj životopis na [email protected]
🌐 Více o nás: www.fagofarma.cz

03/12/2025

🤝 We’ve joined forces with our sister company MB Pharma to launch the Deep Tech project “Development of medicinal products DUOFAG® and TRIOFAG® based on safe and effective bacteriophages.” Together, we’re advancing the future of phage therapy and bringing innovative treatments closer to patients. 🚀🦠

04/11/2025

🎉 New project Genetic Modification to Expand the Potential of Phage Therapy 🦠

We are excited to announce the launch of a new R&D project - “Genetic modification of prophages and bacteria for expanding the possibilities of phage therapy (GMP)” - carried out in collaboration with DYNTEC.

The project focuses on developing genetically modified bacteriophages with enhanced therapeutic properties to tackle antibiotic-resistant pathogens and advance the future of phage therapy.

This project is co-funded by the European Union through the Operational Programme Technology and Application for Competitiveness (OP TAK) and the Ministry of Industry and Trade of the Czech Republic.

17/09/2025

For weeks it felt like the whole phage world disappeared into “proposal caves” 📝☕🦠.
Now that the Horizon call is closed, we’re excited to see phage research and business come alive again!

Good luck to all who submitted — and welcome back to the real phage action. 😉

12/08/2025

🚀 Big news from our sister company MB Pharma! 🐟🔬

We’re excited to share that MB Pharma, in collaboration with Dyntec, has officially launched the clinical trial of FISHFAG – a groundbreaking veterinary medicinal product designed to fight fish infections caused by Aeromonas salmonicida.

💡 Why it matters:
FISHFAG uses active bacteriophages to precisely target harmful bacteria, offering a modern, sustainable approach to improving fish health and aquaculture outcomes.

👏 We’re proud to see MB Pharma and Dyntec working together to evaluate the efficacy and safety of this innovative solution. This milestone reflects the growing impact of phage-based technologies in veterinary medicine.

🌊 Here’s to healthier fish populations and pioneering science in action!

08/08/2025

🚀 We’re on Facebook! 💙
Hello everyone! We’re FAGOFARMA, a Czech biotechnology company 🧬🌱 developing and manufacturing bacteriophage-based products 🦠 — a new hope in the fight against antibiotic resistance 💊❌.

Founded in 2013, we’ve grown step by step to 2023, when we proudly achieved the prestigious GMP certification 🏅 from the State Institute for Drug Control (SÚKL) — becoming only the second site in the Czech Republic 🇨🇿 to meet these highest quality standards ✅.

We work in modern labs and production facilities 🏭 — in Brno (R&D) and Roztoky near Prague (pharmaceutical production, cleanrooms A–D) 🧪.

Our team is currently involved in exciting projects 🔬📚 — from fighting biofilm-forming pathogens to creating clinically ready phage products 🏥.

We’d love for you to follow our journey 📲, share our news 🔄, and join us in shaping the future of medicine 💙.